Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOE.

Saved in:
Bibliographic Details
Title: Serum HDL-cholesterol is associated with the clinical-biological profile of early-stage Parkinson's disease patients independently of APOE.
Authors: Mascioli, Davide1 (AUTHOR), Conti, Matteo1,2 (AUTHOR), Bissacco, Jacopo1 (AUTHOR), Bovenzi, Roberta1 (AUTHOR), Simonetta, Clara1 (AUTHOR), Buttarazzi, Veronica1 (AUTHOR), Mancini, Maria1 (AUTHOR), Bagetta, Silvio1 (AUTHOR), Sancesario, Giulia Maria3 (AUTHOR), Maftei, Daniela1 (AUTHOR), Veltri, Federica1 (AUTHOR), Marchionni, Enrica4 (AUTHOR), Stefani, Alessandro1,2 (AUTHOR), Mercuri, Nicola Biagio1,3 (AUTHOR), Pieri, Massimo5,6 (AUTHOR), Schirinzi, Tommaso1 (AUTHOR) t.schirinzi@yahoo.com
Source: Neurobiology of Aging. Nov2025, Vol. 155, p1-7. 7p.
Database: Academic Search Ultimate
Description
ISSN:01974580
DOI:10.1016/j.neurobiolaging.2025.07.004